Bullish on HOTH Therapeutics citing strong CLEER-001 trial data, high success rate, and recent EU regulatory clearance while the stock trades near $1.05.
HOTH — LONG The author argues HOTH Therapeutics is undervalued at ~$1.05 despite very good data from its CLEER-001 trial and a high reported success rate in trials. They cite last week's EU regulatory green light as a catalyst and believe the market is sleeping on the stock, expecting a massive run soon. The main stated risk is implicit market underappreciation, though no explicit risk is named.
How is this still so low? Very good data from their CLEER-001. Very good Success Rate reported in trials. Plus they just got the EU green light last week. And still for 1.05$. The market is completely sleeping on this. Is somebody in? I think there can be a massive run soon.
This Reddit post, published January 22, 2026, features u/Apprehensive-Ice5690 discussing HOTH. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Apprehensive-Ice5690 · Tickers: HOTH